![SUMOylation inhibitors synergize with FXR agonists in combating liver fibrosis | Nature Communications SUMOylation inhibitors synergize with FXR agonists in combating liver fibrosis | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-019-14138-6/MediaObjects/41467_2019_14138_Fig1_HTML.png)
SUMOylation inhibitors synergize with FXR agonists in combating liver fibrosis | Nature Communications
![Protocol for in vitro phosphorylation of the MUS81-binding region of SLX4 using CDK1-cyclin B - ScienceDirect Protocol for in vitro phosphorylation of the MUS81-binding region of SLX4 using CDK1-cyclin B - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2666166723001107-fx1.jpg)
Protocol for in vitro phosphorylation of the MUS81-binding region of SLX4 using CDK1-cyclin B - ScienceDirect
![Structure-based discovery of nonopioid analgesics acting through the α2A-adrenergic receptor | Science Structure-based discovery of nonopioid analgesics acting through the α2A-adrenergic receptor | Science](https://www.science.org/cms/10.1126/science.abn7065/asset/6df36da9-f0c9-4310-9389-183dd4899f50/assets/images/large/science.abn7065-fa.jpg)
Structure-based discovery of nonopioid analgesics acting through the α2A-adrenergic receptor | Science
![The Tricarboxylic Acid Cycle at the Crossroad Between Cancer and Immunity | Antioxidants & Redox Signaling The Tricarboxylic Acid Cycle at the Crossroad Between Cancer and Immunity | Antioxidants & Redox Signaling](https://www.liebertpub.com/cms/10.1089/ars.2019.7974/asset/images/medium/ars.2019.7974_figure6.jpg)
The Tricarboxylic Acid Cycle at the Crossroad Between Cancer and Immunity | Antioxidants & Redox Signaling
Reduction-Sensitive Dextran–Paclitaxel Polymer–Drug Conjugate: Synthesis, Self-Assembly into Nanoparticles, and In Vitro Anticancer Efficacy | Bioconjugate Chemistry
![Malonylation of Acetyl-CoA carboxylase 1 promotes hepatic steatosis and is attenuated by ketogenic diet in NAFLD - ScienceDirect Malonylation of Acetyl-CoA carboxylase 1 promotes hepatic steatosis and is attenuated by ketogenic diet in NAFLD - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211124723003303-fx1.jpg)
Malonylation of Acetyl-CoA carboxylase 1 promotes hepatic steatosis and is attenuated by ketogenic diet in NAFLD - ScienceDirect
![Identification of the Clinical Development Candidate MRTX849, a Covalent KRASG12C Inhibitor for the Treatment of Cancer | Journal of Medicinal Chemistry Identification of the Clinical Development Candidate MRTX849, a Covalent KRASG12C Inhibitor for the Treatment of Cancer | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.9b02052/asset/images/large/jm9b02052_0011.jpeg)